107 Additional Definitions. In addition, each of the following definitions shall have the respective meanings set forth in the section of this Agreement indicated below. Definition Section Accounting Firm 6.10.2 Alliance Manager 5.1
107 Additional Definitions. The following table identifies the location of definitions set forth in various Sections of the Agreement: [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Definition Section Abandoning Party 10.2(c)(ii)(2) [*] [*] Base Abandonment 10.2(c)(ii) Base Patent Jurisdictions 10.2(c)(i) [*] [*] Competing Program 2.4(c)(i)(1) Confidentiality Agreement 16.8 Continuing Party 10.2(c)(ii)(2) CREATE Act 10.1(a)(iv) Development Plan 5.2 Disclosing Party 11.1(a) Dispute 16.5 [*] [*] Indemnified Party 15.3(a) Indemnifying Party 15.3(a) Infringer 10.3(b) Infringing Product 10.3(a) iPSCs 1.92 Joint Inventions 10.1(a)(iii) Joint Patents 10.1(a)(iii) Joint Steering Committee or JSC 3.1 Joint Territories 10.2(c)(i) [*] [*] Kite Indemnitees 15.1 Kite Withholding Tax Action 9.11 Liabilities 15.1 Materials 4.11(a) [*] [*] Negotiation Period 2.6 Non-Base Abandonment 10.2(c)(ii) Other Joint Patents 10.2(c)(i) Product Infringement 10.3(a) Product Marks 10.7 Project Team 3.2 Receiving Party 11.1(a) Research Plan 4.1 Research Program 4.1 Research Term 4.2 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Royalty Floor 9.6(c)(iii) Royalty Term 9.6(b) [*] [*] Sangamo Indemnitees 15.2 Sangamo Party 6.3 [*] [*] SEC 11.5(b) [*] [*] Third Party Infringement 10.4 Term 13.1 [*] [*] [*] [*] ZFN License 2.6
107 Additional Definitions. Each of the following definitions is set forth in the Section of this Agreement indicated below: Definition Section Accounting Period 10.1 Acquired Party 19.1 Alliance Director 6.9 Breaching Party 18.2.1 [***] [***] [***] [***] Certification Notice 13.10 Chairperson 6.2 [***] [***] Commercial Sublicensees 1.73 Competing Program 4.2 Competitive Infringement 13.7.1.1 Compulsory Sublicensee 1.20 Decision Period 13.7.1.2A Designated Target 2.2.2.3 Designated Target Notice 2.2.2.3 Disclosing Party 1.21 Early Technology Transfer 2.5.1 Expert Committee 9.5.2.2B Failed Target 2.3.1.2A Hit Package 2.3.1.1A H-W Suit Notice 13.10 Indemnified Party 15.3 Definition Section Indemnifying Party 15.3 Initiating Party 13.7.1.2C IP Coordination Team 13.1 Joint Invention 1.54 JOT 6.8 Lead Compound 1.77 LI Compound 1.61 LI Package 2.3.2.1 LO Compound 1.64 LO Package 2.3.3.2 Members 6.2 Minimum Transfer Payment 18.3.7.4C MRT cover page MRT Indemnitees 15.1 MRT Internal Program 2.3.6 MRT Invention 1.54 MRT-Originated Transfer Activities 18.3.4.2 Nomination Package 2.2.2.1 Nomination Package Fee 9.2.2 Nomination Package Split 2.2.2.2 Nomination Package Split Fee 9.2.2.2 Nomination Period 2.2.2.1 Nomination Target 2.2.2.1 Non-Acquired Party 19.1 Non-Breaching Party 18.2.1 Parties cover page Party cover page Patent Term Extensions 13.11 Payment Currency 10.3 Peremptory Notice Period 18.2.1 Ph0Go Package 2.3.3.3 PII/Samples 18.3.7.4B Publishing Notice 17.4.2 Publishing Party 17.4.2 Receiving Party 1.21 Register 13.5 Relative Commercial Value 9.5.2.2A Research Phase 2.1.1 [***] [***] Reverted Compound 13.3.2 Roche cover page Roche Basel cover page Roche Indemnitees 15.2 Roche Invention 1.54 Roche Transfer Activities 18.3.7.4C Roche US cover page [***] [***] [***] [***] Definition Section Settlement 13.7.1.3C SPCs 13.11 Substitution 2.3.1.3D Suit Notice 13.7.1.2A [***] [***] Technology Transfer 2.4.1 Technology Transfer Plan 2.4.1
